Prevalence,Pharmacological Treatment,and Control of Cardiometabolic Risk Factors among Older People in Central Stockholm: A Population-Based Study |
| |
| Authors: | Rui Wang Laura Fratiglioni Yajun Liang Anna-Karin Welmer Weili Xu Francesca Mangialasche Kristina Johnell Chengxuan Qiu |
| |
| Institution: | 1. Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet-Stockholm University, Stockholm, Sweden.; 2. Stockholm Gerontology Research Center, Stockholm, Sweden.; 3. School of Public Health, Jining Medical University, Shandong, China.; 4. Karolinska University Hospital, Stockholm, Sweden.; Heinrich-Heine University, Faculty of Medicine, GERMANY, |
| |
| Abstract: | BackgroundCardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging.ObjectiveWe aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people.MethodsThis population-based study included 3363 participants (age≥60 years, 64.9% women) in the Swedish National study on Aging and Care in Kungsholmen, in central Stockholm, Sweden (2001-2004). Data on demographics, cardiometabolic risk factors (hypertension, obesity, diabetes, and high cholesterol), and medication use were collected through face-to-face interviews, clinical examinations, laboratory tests, and the inpatient register. Cardiometabolic risk factors were defined following the most commonly used criteria. Prevalence was standardized using local census data.ResultsThe age- and sex-standardized prevalence of diabetes, obesity, high cholesterol, and hypertension was 9.5%, 12.8%, 49.7%, and 74.9%, respectively. The prevalence of hypertension and diabetes increased with age, whereas the prevalence of obesity and high cholesterol decreased with age. Forty-nine percent of older adults had two or more cardiometabolic risk factors; 9.8% had three or more. Overall, 55.5% of people with hypertension, 50.3% with diabetes, and 25.0% with high cholesterol received pharmacological treatment. Of those treated pharmacologically, 49.4%, 38.1%, and 85.5% reached therapeutic goals for hypertension (blood pressure<150/90 mmHg), diabetes (glycated haemoglobin<7%), and high cholesterol (total cholesterol<6.22 mmol/l), respectively.ConclusionsHypertension, high cholesterol, and clustering of cardiometabolic risk factors were common among older people in Stockholm, but pharmacological treatment and control of these major factors can be improved. Appropriate management of cardiometabolic profiles among older people may help improve cardiovascular health and achieve healthy aging. |
| |
| Keywords: | |
|
|
